Behrad Derakhshan Edgewise Therapeutics, Inc. (EWTX) insider trading activity

Behrad Derakhshan is Chief Business Officer of Edgewise Therapeutics, Inc.. Currently has a direct ownership of 23,645 shares of EWTX, which is worth approximately $316,606. The most recent transaction as insider was on Aug 12, 2025, when has been sold 2,491 shares (Common Stock) at a price of $13.39 per share, resulting in proceeds of $33,354. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.6K

16.16% 3M change

76.17% 12M change

Total Value Held $316,606

Behrad Derakhshan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 12 2025	SELL Open market or private sale	$33,354 $13.39 p/Share	2,491 Reduced 9.53%	23,645 Common Stock
Aug 12 2025	BUY Exercise of conversion of derivative security	-	5,781 Added 18.11%	26,136 Common Stock
May 02 2025	SELL Open market or private sale	$27,816 $16.45 p/Share	1,691 Reduced 7.67%	20,355 Common Stock
May 01 2025	BUY Exercise of conversion of derivative security	-	5,209 Added 19.11%	22,046 Common Stock
Feb 05 2025	SELL Open market or private sale	$300,300 $30.03 p/Share	10,000 Reduced 37.26%	16,837 Common Stock
Feb 05 2025	BUY Exercise of conversion of derivative security	$19,300 $1.93 p/Share	10,000 Added 27.15%	26,837 Common Stock
Sep 20 2024	SELL Open market or private sale	$1,221,234 $29.03 p/Share	42,068 Reduced 73.56%	15,121 Common Stock
Sep 20 2024	BUY Exercise of conversion of derivative security	$81,191 $1.93 p/Share	42,068 Added 42.38%	57,189 Common Stock
May 02 2024	SELL Open market or private sale	$32,487 $18.91 p/Share	1,718 Reduced 11.35%	13,422 Common Stock
May 01 2024	BUY Exercise of conversion of derivative security	-	5,208 Added 25.59%	15,140 Common Stock
Feb 09 2024	SELL Open market or private sale	$96,192 $20.04 p/Share	4,800 Reduced 40.61%	7,020 Common Stock
Feb 09 2024	BUY Exercise of conversion of derivative security	$9,264 $1.93 p/Share	4,800 Added 28.88%	11,820 Common Stock
Feb 08 2024	SELL Open market or private sale	$92,046 $20.01 p/Share	4,600 Reduced 39.59%	7,020 Common Stock
Feb 08 2024	BUY Exercise of conversion of derivative security	$8,878 $1.93 p/Share	4,600 Added 28.36%	11,620 Common Stock
Feb 07 2024	SELL Open market or private sale	$12,000 $20.0 p/Share	600 Reduced 7.87%	7,020 Common Stock
Feb 07 2024	BUY Exercise of conversion of derivative security	$1,158 $1.93 p/Share	600 Added 7.3%	7,620 Common Stock
May 02 2023	SELL Open market or private sale	$15,548 $8.9 p/Share	1,747 Reduced 19.93%	7,020 Common Stock
May 01 2023	BUY Exercise of conversion of derivative security	-	5,208 Added 37.27%	8,767 Common Stock

Behrad Derakhshan

Chief Business Officer

Boulder, CO

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EWTX shares.

Notify only if

Value

Insider Trading

Get notified when an Edgewise Therapeutics, Inc. insider buys or sells EWTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Edgewise Therapeutics, Inc.

Track Activities on EWTX

Account